Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double Blind, Placebo Controlled Detrol LA "Add-On" To Alpha-Blocker Study In Men With Persistent Overactive Bladder Symptoms Of Urinary Frequency And Urgency With/Without Urgency Incontinence After Previous Monotherapy With Alpha Blocker.
Brief Summary: An interventional active/placebo double blinded parallel randomized controlled study in which at 12 weeks of treatment, the primary endpoint of patient perception of bladder condition is measured along with associated safety and other secondary endpoints like bladder diary endpoints, quality of life and patient treatment satisfaction.

Patients included in the study must have symptoms of OAB (frequency of at least 8 per day and Urgency of at least 1 episode per day confirmed by bladder diary).

Patients are not eligible to enroll in the study if they have/had significant hepatic or renal disease, history of radiation treatment.


Options:
A: Intervention Type: DRUG; Name: Detrol LA; Assigned to Arm(s): N/A
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo tamsulosin hydrochloride OCAS 0.4 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg | Arm Label: TOCAS 0.4 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg, Drug: tamsulosin hydrochloride OCAS 0.4 mg | Arm Label: FDC 0.4 mg/6 mg; Type: EXPERIMENTAL; Interventions: Drug: Placebo tamsulosin hydrochloride OCAS 0.4 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg, Drug: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg) | Arm Label: FDC 0.4 mg/9 mg; Type: EXPERIMENTAL; Interventions: Drug: Placebo tamsulosin hydrochloride OCAS 0.4 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg, Drug: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg) | Intervention Type: DRUG; Name: Placebo tamsulosin hydrochloride OCAS 0.4 mg; Assigned to Arm(s): FDC 0.4 mg/6 mg, FDC 0.4 mg/9 mg, Placebo | Intervention Type: DRUG; Name: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg; Assigned to Arm(s): FDC 0.4 mg/9 mg, Placebo, TOCAS 0.4 mg | Intervention Type: DRUG; Name: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg; Assigned to Arm(s): FDC 0.4 mg/6 mg, Placebo, TOCAS 0.4 mg | Intervention Type: DRUG; Name: tamsulosin hydrochloride OCAS 0.4 mg; Assigned to Arm(s): TOCAS 0.4 mg | Intervention Type: DRUG; Name: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg); Assigned to Arm(s): FDC 0.4 mg/6 mg | Intervention Type: DRUG; Name: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg); Assigned to Arm(s): FDC 0.4 mg/9 mg
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo to solifenacin, Drug: Placebo to tamsulosin | Arm Label: 6 mg Solifenacin + 0.4 mg Tamsulosin; Type: EXPERIMENTAL; Interventions: Drug: solifenacin succinate, Drug: tamsulosin hydrochloride | Arm Label: 9 mg Solifenacin + 0.4 mg Tamsulosin; Type: EXPERIMENTAL; Interventions: Drug: solifenacin succinate, Drug: tamsulosin hydrochloride | Intervention Type: DRUG; Name: solifenacin succinate; Assigned to Arm(s): 6 mg Solifenacin + 0.4 mg Tamsulosin, 9 mg Solifenacin + 0.4 mg Tamsulosin | Intervention Type: DRUG; Name: tamsulosin hydrochloride; Assigned to Arm(s): 6 mg Solifenacin + 0.4 mg Tamsulosin, 9 mg Solifenacin + 0.4 mg Tamsulosin | Intervention Type: DRUG; Name: Placebo to solifenacin; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Placebo to tamsulosin; Assigned to Arm(s): Placebo
D: Arm Label: A; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: solifenacin succinate | Arm Label: C; Type: ACTIVE_COMPARATOR; Interventions: Drug: solifenacin succinate | Arm Label: D; Type: ACTIVE_COMPARATOR; Interventions: Drug: solifenacin succinate | Arm Label: E; Type: ACTIVE_COMPARATOR; Interventions: Drug: tamsulosin hydrochloride | Arm Label: F; Type: ACTIVE_COMPARATOR; Interventions: Drug: tamsulosin hydrochloride, Drug: solifenacin succinate | Arm Label: G; Type: ACTIVE_COMPARATOR; Interventions: Drug: tamsulosin hydrochloride, Drug: solifenacin succinate | Arm Label: H; Type: ACTIVE_COMPARATOR; Interventions: Drug: tamsulosin hydrochloride, Drug: solifenacin succinate | Intervention Type: DRUG; Name: tamsulosin hydrochloride; Assigned to Arm(s): E, F, G, H | Intervention Type: DRUG; Name: solifenacin succinate; Assigned to Arm(s): B, C, D, F, G, H | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): A

Answer: A